Abbvie
- All
- News
-
Oxford To Study Anti-Inflammatory Drug As Covid Treatment
Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose existing drugs as potential coronavirus therapies.
-
Hepatitis C Drugs Tied to Potentially Lethal Liver Damage: US
Two drugs used to treat hepatitis C could cause liver damage, leading in some cases to death, the US Food and Drug Administration warned Thursday.
-
Google's Calico Partners AbbVie to Battle Age-Related Illnesses
The companies will combine strengths to discover, develop and bring to market new therapies.
-
Oxford To Study Anti-Inflammatory Drug As Covid Treatment
Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose existing drugs as potential coronavirus therapies.
-
Hepatitis C Drugs Tied to Potentially Lethal Liver Damage: US
Two drugs used to treat hepatitis C could cause liver damage, leading in some cases to death, the US Food and Drug Administration warned Thursday.
-
Google's Calico Partners AbbVie to Battle Age-Related Illnesses
The companies will combine strengths to discover, develop and bring to market new therapies.
